期刊文献+

pH值对右旋布洛芬体外透皮性能的影响研究 被引量:2

Effect of pH Value on in Vitro Percutaneous Permeability for Dextral Ibuprofen
原文传递
导出
摘要 目的:研究pH值对右旋布洛芬(DI)体外透皮性能的影响,为其透皮给药制剂的开发提供实验依据。方法:建立DI的高效液相色谱分析方法,测定其在水和不同pH的磷酸盐缓冲液(PBS)中的平衡溶解度;用摇瓶法测定DI的正辛醇溶液在正辛醇饱和蒸馏水与不同pH的PBS中的表观油水分配系数;以稳态渗透速率(Js)和渗透系数(Ps)为评价指标,检测不同pH的PBS对DI体外透皮性能的影响。结果:32℃时,DI在水中难溶;在pH7.4的PBS中平衡溶解度、Js、Ps均最大,表观油水分配系数极小,分别为5421.6μg·mL-1、339.97μg·cm-2·h-1、0.063cm·h-1、0.17。结论:pH值对DI体外透皮性能有很大影响,pH7.4时DI有较高的溶解度、脂溶性及较理想的皮肤通透性。 OBJECTIVE: To study the effect of pH value on in-vitro percutaneous permeability of dextral ibuprofen (DI) and to provide experimental basis for the development of percutaneous agent. METHODS: HPLC method was established to determine the equilibrium solubility of DI in water and phosphate buffer solution (PBS) with different pH values. Shaking-flask method was used to measure the apparent oil-water distribution coefficient of DI in the n-octyl alcohol saturated water or PBS with different pH values. The effect of PBS with different pH values on in-vitro percutaneous permeability of DI was evaluated using the steady-state permeation rate (Js) and permeation coefficient (Ps) as index. RESULTS: At 32 ℃, DI was hardly soluble in water; the equilibrium solubility, J,, Ps of DI in PBS with pH 7.4 were the highest while apparent oil-water distribution coefficient was close to minimum value. They were 5 421.6 μg·mL-1, 339.97 μg·cm2-h-1, 0.063 cm·h-1, 0.17, respectively. CONCLUSION: The in-vitro percutaneous permeability of DI is greatly influenced by the pH of media. Adjusting pH to 7.4, higher solubility and liposolubility of dru~ are maintained as well as Dercutaneous t^ermeabilitv.
出处 《中国药房》 CAS CSCD 北大核心 2011年第37期3489-3491,共3页 China Pharmacy
关键词 右旋布洛芬 PH 透皮 Dextro ibuprofen pH Percutaneous permeation
  • 相关文献

参考文献5

二级参考文献22

  • 1马金龙,赵波,乔连明,周文杰,孙桂珍.布洛芬糖浆剂的研制[J].药学与临床研究,1998,13(4):14-15. 被引量:1
  • 2税庆华,钱雪,朱启登.布洛芬搽剂中有关物质的HPLC法测定[J].齐鲁药事,2006,25(1):24-26. 被引量:5
  • 3Bon A, Jongejan RC. Treatment of non- malignant pain in the Dutch GP population: an analysis of treatment standards, prescription habits and basic attitudes [J ]. Clin Rheumatol, 2001,20 (Suppl 1) : 225.
  • 4国家食品药品监督管理局编.国家药品标准(试行)WS-1106(X-834)2002右旋布洛芬[S].2002.
  • 5Jancic B, Ivanovic D, Medenica M, Malenovic A, Dimkovic N. J. Chromatog. A, 2005, 1088(1/2) : 187 -192.
  • 6Jancic B, Medenica M, Ivanovic D, Malenovic A, Dimkovic N. Anal. Bioanal. Chem. , 2005, 383(4) :687 -694.
  • 7Malenovic A, Medenica M, IvanovicD, JancicB. Chromatographia, 2006, 63(S) : 95 -100.
  • 8MalenovicA, IvanovicD, Medenica M, Jancic B, Markovic S. J. Sep. Sci., 2004, 27(13): 1087-1092.
  • 9MalenovicA, Ivanovic D, Medenica M, Jancic B, Markovic S. J. Chromatog. A, 2006, 1131(1/2) : 67 -73.
  • 10Liu J F, Sun J, Wang Y J, Liu X H, Sun Y H, Xu H, He Z G. J. Chromatog. A, 2007, 1164(1/2) : 129 -138.

共引文献11

同被引文献11

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部